TNF-α inhibitors (Infliximab, Adalimumab, Certolizumab)

Biologic DMARD (anti-TNF)

Compatible — certolizumab preferred through third trimester (minimal placental transfer).

Evidence-based OB-GYN pharmacology reference for clinical practice and MRCOG preparation.